tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Buy Rating Reaffirmed for Syndax Pharmaceuticals Despite Black Box Warning on Revuforj
PremiumRatingsBuy Rating Reaffirmed for Syndax Pharmaceuticals Despite Black Box Warning on Revuforj
4d ago
Buy Rating for Syndax Pharmaceuticals Driven by FDA Approval of Revuforj and Market Expansion Potential
Premium
Ratings
Buy Rating for Syndax Pharmaceuticals Driven by FDA Approval of Revuforj and Market Expansion Potential
5d ago
Syndax Pharmaceuticals Gains FDA Approval for Revuforj
Premium
Company Announcements
Syndax Pharmaceuticals Gains FDA Approval for Revuforj
7d ago
Syndax assumed with a Buy at H.C. Wainwright
PremiumThe FlySyndax assumed with a Buy at H.C. Wainwright
16d ago
Strategic Positioning and Competitive Edge: Syndax Pharmaceuticals’ Buy Rating Reinforced by Revuforj’s Milestones in Leukemia Treatment
Premium
Ratings
Strategic Positioning and Competitive Edge: Syndax Pharmaceuticals’ Buy Rating Reinforced by Revuforj’s Milestones in Leukemia Treatment
1M ago
Syndax announces updated NCCN Guidelines for AML
Premium
The Fly
Syndax announces updated NCCN Guidelines for AML
1M ago
Syndax assumed with a Buy at Guggenheim
PremiumThe FlySyndax assumed with a Buy at Guggenheim
2M ago
Syndax assumed with a Buy at Guggenheim
Premium
The Fly
Syndax assumed with a Buy at Guggenheim
2M ago
Syndax Pharmaceuticals’ Axatilimab Study: A Potential Breakthrough for IPF Treatment
Premium
Company Announcements
Syndax Pharmaceuticals’ Axatilimab Study: A Potential Breakthrough for IPF Treatment
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100